Skip to main content
. 2020 Nov 12;5:25. doi: 10.1186/s41181-020-00106-9

Table 6.

Overview of [68Ga]Ga-PSMA-11 productions (EOS)

Site HNO3 [mol/L] I
[μA]
Beam
time
[min]
N Product activity Notes
[GBq] [mCi]
UM 0.2 30–40 60 3 1.6 ± 0.3 43 ± 9 Validation runs
UM 0.2 30–40 60 35 1.7 ± 0.2 45 ± 6 Clinical
GEMS 0.3 30 64 ± 4 3 2.1 ± 0.4 57 ± 10 R&D efforts
RPA 0.3 35 60 14 1.6 ± 0.1 44 ± 3 Final validation and clinical (5) runs